Children's Hospital Colorado
Aurora, Colorado, 80045, United States
NCT Number: NCT02723305
This study plans to learn more about how to measure the way the the body's energy system works in boys with Klinefelter syndrome, including the heart, lungs, muscles, and liver. This is important to know so that investigators understand how hormones and an extra X chromosome relate to diseases such as diabetes, extra weight gain, heart disease and liver diseases.
Looking for future studies?
Notify Me12 year–17 year
Male
Observational
Aurora, Colorado, 80045, United States
Klinefelter syndrome (KS) is the most common chromosomal abnormality in males and is associated with primary gonadal failure in adolescence and a high morbidity and mortality from cardiovascular-related diseases (CVD) in adulthood. Recent studies in children and adolescent boys with KS have found a high prevalence of CVD risk markers, however the underlying mechanisms have not been explored. Our central hypothesis is that pubertal boys with KS have relative testosterone deficiency resulting in abnormal energy metabolism that predisposes them to later CVD, and that exogenous testosterone will modify these abnormalities.
In this study, investigators will measure markers of cardiometabolic risk in pubertal boys with KS.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline
The primary outcome will be peak oxygen consumption (VO2 peak) during exercise on a bicycle ergometer
Time frame: baseline
Percent body fat by dual-energy x-ray absorptiometry
Time frame: baseline
Intrahepatic fat by abdominal magnetic resonance imaging
Time frame: baseline
Rate of mitochondrial phosphorylation by 31-phosphorus magnetic resonance spectroscopy of the calf muscles
Time frame: baseline
oral disposition index with Glucola
University of Colorado, Denver
Other
Cardiometabolic Profiles of Pubertal Boys With Klinefelter Syndrome With or Without One Year of Exogenous Testosterone Treatment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01585831
Chromosome Aberrations, Chromosome Disorders
Aurora, Colorado, United States
View Trial DetailsNCT01206270
Chromosome Disorders, Congenital Abnormalities
Rome, Lazio, Italy
View Trial DetailsNCT04252001
Addison Disease, Addison's Disease
Ghent, Belgium
View Trial DetailsNCT01918280
Azoospermia, Chromosome Disorders
Bordeaux, France
View Trial Details